# OnCo record rec-4539 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rec-4539/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rec-4539" ;
  schema:name "REC-4539"@en ;
  schema:alternateName "EXS74539"@en ;
  schema:description "REC-4539 is an experimental small molecule LSD1 inhibitor from Recursion Pharmaceuticals, in phase 1 trials for small-cell lung cancer, acute myeloid leukaemia and solid tumours."@en ;
  schema:url <https://onco.cc/drugs/rec-4539/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.recursion.com/pipeline>, <https://clinicaltrials.gov/api/v2/studies/NCT07517198>, <https://clinicaltrials.gov/search?intr=REC-4539> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule LSD1 inhibitor" ;
  onco:cancers <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/lsd1/> ;
  onco:companies <https://onco.cc/companies/recursion/> ;
  onco:trials <https://onco.cc/trials/nct07517198/> .